nodes	percent_of_prediction	percent_of_DWPC	metapath
Lincomycin—Clindamycin—CYP3A4—breast cancer	0.0159	1	CrCbGaD
Lincomycin—Pancytopenia—Capecitabine—breast cancer	0.00102	0.00104	CcSEcCtD
Lincomycin—Oesophagitis—Doxorubicin—breast cancer	0.00101	0.00102	CcSEcCtD
Lincomycin—Urticaria—Melphalan—breast cancer	0.00101	0.00102	CcSEcCtD
Lincomycin—Phlebitis—Epirubicin—breast cancer	0.001	0.00102	CcSEcCtD
Lincomycin—Vertigo—Irinotecan—breast cancer	0.001	0.00102	CcSEcCtD
Lincomycin—Neutropenia—Capecitabine—breast cancer	0.001	0.00102	CcSEcCtD
Lincomycin—Leukopenia—Irinotecan—breast cancer	0.001	0.00102	CcSEcCtD
Lincomycin—Leukopenia—Mitoxantrone—breast cancer	0.001	0.00102	CcSEcCtD
Lincomycin—Thrombophlebitis—Epirubicin—breast cancer	0.001	0.00102	CcSEcCtD
Lincomycin—Diarrhoea—Chlorambucil—breast cancer	0.000994	0.00101	CcSEcCtD
Lincomycin—Hepatic function abnormal—Epirubicin—breast cancer	0.00099	0.00101	CcSEcCtD
Lincomycin—Erythema multiforme—Paclitaxel—breast cancer	0.00099	0.00101	CcSEcCtD
Lincomycin—Urticaria—Goserelin—breast cancer	0.000981	0.000997	CcSEcCtD
Lincomycin—Hypersensitivity—Vinblastine—breast cancer	0.000981	0.000997	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Docetaxel—breast cancer	0.00098	0.000996	CcSEcCtD
Lincomycin—Tinnitus—Paclitaxel—breast cancer	0.000976	0.000992	CcSEcCtD
Lincomycin—Abdominal pain—Goserelin—breast cancer	0.000976	0.000992	CcSEcCtD
Lincomycin—Body temperature increased—Goserelin—breast cancer	0.000976	0.000992	CcSEcCtD
Lincomycin—Leukopenia—Gemcitabine—breast cancer	0.000975	0.000991	CcSEcCtD
Lincomycin—Stomatitis—Docetaxel—breast cancer	0.000964	0.000979	CcSEcCtD
Lincomycin—Jaundice—Docetaxel—breast cancer	0.000964	0.000979	CcSEcCtD
Lincomycin—Leukopenia—Fluorouracil—breast cancer	0.000958	0.000974	CcSEcCtD
Lincomycin—Hypersensitivity—Tamoxifen—breast cancer	0.000953	0.000968	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Capecitabine—breast cancer	0.000949	0.000965	CcSEcCtD
Lincomycin—Pain—Vinorelbine—breast cancer	0.000946	0.000961	CcSEcCtD
Lincomycin—Jaundice—Capecitabine—breast cancer	0.000933	0.000948	CcSEcCtD
Lincomycin—Stomatitis—Capecitabine—breast cancer	0.000933	0.000948	CcSEcCtD
Lincomycin—Hypersensitivity—Melphalan—breast cancer	0.000933	0.000948	CcSEcCtD
Lincomycin—Phlebitis—Doxorubicin—breast cancer	0.00093	0.000945	CcSEcCtD
Lincomycin—Thrombophlebitis—Doxorubicin—breast cancer	0.000925	0.00094	CcSEcCtD
Lincomycin—Vomiting—Chlorambucil—breast cancer	0.000924	0.000939	CcSEcCtD
Lincomycin—Agranulocytosis—Docetaxel—breast cancer	0.000923	0.000938	CcSEcCtD
Lincomycin—Hepatic function abnormal—Doxorubicin—breast cancer	0.000916	0.000931	CcSEcCtD
Lincomycin—Pruritus—Tamoxifen—breast cancer	0.000915	0.00093	CcSEcCtD
Lincomycin—Anaphylactic shock—Irinotecan—breast cancer	0.000912	0.000927	CcSEcCtD
Lincomycin—Anaphylactic shock—Mitoxantrone—breast cancer	0.000912	0.000927	CcSEcCtD
Lincomycin—Diarrhoea—Vinblastine—breast cancer	0.000911	0.000926	CcSEcCtD
Lincomycin—Hypersensitivity—Goserelin—breast cancer	0.00091	0.000925	CcSEcCtD
Lincomycin—Dermatitis bullous—Epirubicin—breast cancer	0.000906	0.00092	CcSEcCtD
Lincomycin—Pain—Thiotepa—breast cancer	0.000903	0.000918	CcSEcCtD
Lincomycin—Shock—Irinotecan—breast cancer	0.000898	0.000912	CcSEcCtD
Lincomycin—Shock—Mitoxantrone—breast cancer	0.000898	0.000912	CcSEcCtD
Lincomycin—Pruritus—Melphalan—breast cancer	0.000896	0.00091	CcSEcCtD
Lincomycin—Agranulocytosis—Capecitabine—breast cancer	0.000893	0.000908	CcSEcCtD
Lincomycin—Anaphylactic shock—Gemcitabine—breast cancer	0.000889	0.000903	CcSEcCtD
Lincomycin—Diarrhoea—Tamoxifen—breast cancer	0.000885	0.000899	CcSEcCtD
Lincomycin—Urticaria—Vinorelbine—breast cancer	0.000879	0.000893	CcSEcCtD
Lincomycin—Abdominal pain—Vinorelbine—breast cancer	0.000874	0.000889	CcSEcCtD
Lincomycin—Body temperature increased—Vinorelbine—breast cancer	0.000874	0.000889	CcSEcCtD
Lincomycin—Pruritus—Goserelin—breast cancer	0.000874	0.000888	CcSEcCtD
Lincomycin—Anaphylactic shock—Fluorouracil—breast cancer	0.000874	0.000888	CcSEcCtD
Lincomycin—Diarrhoea—Melphalan—breast cancer	0.000866	0.00088	CcSEcCtD
Lincomycin—Nausea—Chlorambucil—breast cancer	0.000863	0.000877	CcSEcCtD
Lincomycin—Liver function test abnormal—Methotrexate—breast cancer	0.000854	0.000868	CcSEcCtD
Lincomycin—Hypotension—Mitoxantrone—breast cancer	0.000853	0.000866	CcSEcCtD
Lincomycin—Hypotension—Irinotecan—breast cancer	0.000853	0.000866	CcSEcCtD
Lincomycin—Vomiting—Vinblastine—breast cancer	0.000846	0.00086	CcSEcCtD
Lincomycin—Diarrhoea—Goserelin—breast cancer	0.000845	0.000859	CcSEcCtD
Lincomycin—Erythema multiforme—Docetaxel—breast cancer	0.000839	0.000853	CcSEcCtD
Lincomycin—Urticaria—Thiotepa—breast cancer	0.000839	0.000853	CcSEcCtD
Lincomycin—Dermatitis bullous—Doxorubicin—breast cancer	0.000838	0.000851	CcSEcCtD
Lincomycin—Abdominal pain—Thiotepa—breast cancer	0.000835	0.000849	CcSEcCtD
Lincomycin—Body temperature increased—Thiotepa—breast cancer	0.000835	0.000849	CcSEcCtD
Lincomycin—Angioedema—Paclitaxel—breast cancer	0.000833	0.000847	CcSEcCtD
Lincomycin—Hypotension—Gemcitabine—breast cancer	0.00083	0.000844	CcSEcCtD
Lincomycin—Vomiting—Tamoxifen—breast cancer	0.000822	0.000836	CcSEcCtD
Lincomycin—Vertigo—Paclitaxel—breast cancer	0.000819	0.000832	CcSEcCtD
Lincomycin—Hypotension—Fluorouracil—breast cancer	0.000817	0.00083	CcSEcCtD
Lincomycin—Leukopenia—Paclitaxel—breast cancer	0.000816	0.000829	CcSEcCtD
Lincomycin—Rash—Tamoxifen—breast cancer	0.000815	0.000829	CcSEcCtD
Lincomycin—Hypersensitivity—Vinorelbine—breast cancer	0.000815	0.000828	CcSEcCtD
Lincomycin—Dermatitis—Tamoxifen—breast cancer	0.000815	0.000828	CcSEcCtD
Lincomycin—Erythema multiforme—Capecitabine—breast cancer	0.000813	0.000826	CcSEcCtD
Lincomycin—Vomiting—Melphalan—breast cancer	0.000805	0.000818	CcSEcCtD
Lincomycin—Tinnitus—Capecitabine—breast cancer	0.000801	0.000814	CcSEcCtD
Lincomycin—Liver function test abnormal—Epirubicin—breast cancer	0.000799	0.000812	CcSEcCtD
Lincomycin—Rash—Melphalan—breast cancer	0.000798	0.000811	CcSEcCtD
Lincomycin—Dermatitis—Melphalan—breast cancer	0.000798	0.000811	CcSEcCtD
Lincomycin—Nausea—Vinblastine—breast cancer	0.000791	0.000803	CcSEcCtD
Lincomycin—Vomiting—Goserelin—breast cancer	0.000785	0.000798	CcSEcCtD
Lincomycin—Pruritus—Vinorelbine—breast cancer	0.000783	0.000795	CcSEcCtD
Lincomycin—Pain—Irinotecan—breast cancer	0.00078	0.000793	CcSEcCtD
Lincomycin—Pain—Mitoxantrone—breast cancer	0.00078	0.000793	CcSEcCtD
Lincomycin—Rash—Goserelin—breast cancer	0.000779	0.000791	CcSEcCtD
Lincomycin—Hypersensitivity—Thiotepa—breast cancer	0.000778	0.000791	CcSEcCtD
Lincomycin—Dermatitis—Goserelin—breast cancer	0.000778	0.000791	CcSEcCtD
Lincomycin—Nausea—Tamoxifen—breast cancer	0.000768	0.000781	CcSEcCtD
Lincomycin—Abdominal discomfort—Methotrexate—breast cancer	0.000766	0.000779	CcSEcCtD
Lincomycin—Pain—Gemcitabine—breast cancer	0.00076	0.000772	CcSEcCtD
Lincomycin—Pancytopenia—Methotrexate—breast cancer	0.000759	0.000771	CcSEcCtD
Lincomycin—Diarrhoea—Vinorelbine—breast cancer	0.000757	0.000769	CcSEcCtD
Lincomycin—Nausea—Melphalan—breast cancer	0.000752	0.000764	CcSEcCtD
Lincomycin—Neutropenia—Methotrexate—breast cancer	0.000747	0.00076	CcSEcCtD
Lincomycin—Pruritus—Thiotepa—breast cancer	0.000747	0.00076	CcSEcCtD
Lincomycin—Pain—Fluorouracil—breast cancer	0.000747	0.000759	CcSEcCtD
Lincomycin—Anaphylactic shock—Paclitaxel—breast cancer	0.000744	0.000756	CcSEcCtD
Lincomycin—Liver function test abnormal—Doxorubicin—breast cancer	0.000739	0.000751	CcSEcCtD
Lincomycin—Nausea—Goserelin—breast cancer	0.000734	0.000746	CcSEcCtD
Lincomycin—Shock—Paclitaxel—breast cancer	0.000732	0.000744	CcSEcCtD
Lincomycin—Urticaria—Mitoxantrone—breast cancer	0.000725	0.000737	CcSEcCtD
Lincomycin—Diarrhoea—Thiotepa—breast cancer	0.000723	0.000735	CcSEcCtD
Lincomycin—Abdominal pain—Irinotecan—breast cancer	0.000721	0.000733	CcSEcCtD
Lincomycin—Body temperature increased—Irinotecan—breast cancer	0.000721	0.000733	CcSEcCtD
Lincomycin—Body temperature increased—Mitoxantrone—breast cancer	0.000721	0.000733	CcSEcCtD
Lincomycin—Abdominal pain—Mitoxantrone—breast cancer	0.000721	0.000733	CcSEcCtD
Lincomycin—Pancytopenia—Epirubicin—breast cancer	0.00071	0.000722	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000707	0.000718	CcSEcCtD
Lincomycin—Vomiting—Vinorelbine—breast cancer	0.000703	0.000715	CcSEcCtD
Lincomycin—Body temperature increased—Gemcitabine—breast cancer	0.000703	0.000714	CcSEcCtD
Lincomycin—Neutropenia—Epirubicin—breast cancer	0.000699	0.000711	CcSEcCtD
Lincomycin—Rash—Vinorelbine—breast cancer	0.000697	0.000709	CcSEcCtD
Lincomycin—Dermatitis—Vinorelbine—breast cancer	0.000697	0.000708	CcSEcCtD
Lincomycin—Hypotension—Paclitaxel—breast cancer	0.000695	0.000707	CcSEcCtD
Lincomycin—Stomatitis—Methotrexate—breast cancer	0.000695	0.000706	CcSEcCtD
Lincomycin—Urticaria—Fluorouracil—breast cancer	0.000694	0.000705	CcSEcCtD
Lincomycin—Leukopenia—Docetaxel—breast cancer	0.000692	0.000703	CcSEcCtD
Lincomycin—Body temperature increased—Fluorouracil—breast cancer	0.000691	0.000702	CcSEcCtD
Lincomycin—Vertigo—Capecitabine—breast cancer	0.000672	0.000683	CcSEcCtD
Lincomycin—Hypersensitivity—Mitoxantrone—breast cancer	0.000672	0.000683	CcSEcCtD
Lincomycin—Hypersensitivity—Irinotecan—breast cancer	0.000672	0.000683	CcSEcCtD
Lincomycin—Vomiting—Thiotepa—breast cancer	0.000672	0.000683	CcSEcCtD
Lincomycin—Leukopenia—Capecitabine—breast cancer	0.00067	0.000681	CcSEcCtD
Lincomycin—Rash—Thiotepa—breast cancer	0.000666	0.000677	CcSEcCtD
Lincomycin—Dermatitis—Thiotepa—breast cancer	0.000666	0.000676	CcSEcCtD
Lincomycin—Agranulocytosis—Methotrexate—breast cancer	0.000665	0.000676	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000661	0.000672	CcSEcCtD
Lincomycin—Pancytopenia—Doxorubicin—breast cancer	0.000657	0.000668	CcSEcCtD
Lincomycin—Nausea—Vinorelbine—breast cancer	0.000657	0.000668	CcSEcCtD
Lincomycin—Stomatitis—Epirubicin—breast cancer	0.00065	0.000661	CcSEcCtD
Lincomycin—Jaundice—Epirubicin—breast cancer	0.00065	0.000661	CcSEcCtD
Lincomycin—Neutropenia—Doxorubicin—breast cancer	0.000647	0.000658	CcSEcCtD
Lincomycin—Hypersensitivity—Fluorouracil—breast cancer	0.000644	0.000654	CcSEcCtD
Lincomycin—Pain—Paclitaxel—breast cancer	0.000636	0.000647	CcSEcCtD
Lincomycin—Anaphylactic shock—Docetaxel—breast cancer	0.000631	0.000641	CcSEcCtD
Lincomycin—Pruritus—Gemcitabine—breast cancer	0.000629	0.000639	CcSEcCtD
Lincomycin—Nausea—Thiotepa—breast cancer	0.000628	0.000638	CcSEcCtD
Lincomycin—Diarrhoea—Mitoxantrone—breast cancer	0.000624	0.000634	CcSEcCtD
Lincomycin—Diarrhoea—Irinotecan—breast cancer	0.000624	0.000634	CcSEcCtD
Lincomycin—Agranulocytosis—Epirubicin—breast cancer	0.000622	0.000633	CcSEcCtD
Lincomycin—Shock—Docetaxel—breast cancer	0.00062	0.000631	CcSEcCtD
Lincomycin—Pruritus—Fluorouracil—breast cancer	0.000618	0.000628	CcSEcCtD
Lincomycin—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000612	0.000622	CcSEcCtD
Lincomycin—Diarrhoea—Gemcitabine—breast cancer	0.000608	0.000618	CcSEcCtD
Lincomycin—Erythema multiforme—Methotrexate—breast cancer	0.000605	0.000615	CcSEcCtD
Lincomycin—Jaundice—Doxorubicin—breast cancer	0.000602	0.000611	CcSEcCtD
Lincomycin—Stomatitis—Doxorubicin—breast cancer	0.000602	0.000611	CcSEcCtD
Lincomycin—Shock—Capecitabine—breast cancer	0.000601	0.00061	CcSEcCtD
Lincomycin—Diarrhoea—Fluorouracil—breast cancer	0.000598	0.000608	CcSEcCtD
Lincomycin—Tinnitus—Methotrexate—breast cancer	0.000597	0.000606	CcSEcCtD
Lincomycin—Urticaria—Paclitaxel—breast cancer	0.000591	0.000601	CcSEcCtD
Lincomycin—Hypotension—Docetaxel—breast cancer	0.000589	0.000599	CcSEcCtD
Lincomycin—Body temperature increased—Paclitaxel—breast cancer	0.000588	0.000598	CcSEcCtD
Lincomycin—Abdominal pain—Paclitaxel—breast cancer	0.000588	0.000598	CcSEcCtD
Lincomycin—Vomiting—Mitoxantrone—breast cancer	0.00058	0.000589	CcSEcCtD
Lincomycin—Vomiting—Irinotecan—breast cancer	0.00058	0.000589	CcSEcCtD
Lincomycin—Agranulocytosis—Doxorubicin—breast cancer	0.000576	0.000585	CcSEcCtD
Lincomycin—Rash—Irinotecan—breast cancer	0.000575	0.000585	CcSEcCtD
Lincomycin—Rash—Mitoxantrone—breast cancer	0.000575	0.000585	CcSEcCtD
Lincomycin—Dermatitis—Mitoxantrone—breast cancer	0.000575	0.000584	CcSEcCtD
Lincomycin—Dermatitis—Irinotecan—breast cancer	0.000575	0.000584	CcSEcCtD
Lincomycin—Hypotension—Capecitabine—breast cancer	0.000571	0.00058	CcSEcCtD
Lincomycin—Erythema multiforme—Epirubicin—breast cancer	0.000566	0.000575	CcSEcCtD
Lincomycin—Vomiting—Gemcitabine—breast cancer	0.000565	0.000574	CcSEcCtD
Lincomycin—Rash—Gemcitabine—breast cancer	0.00056	0.000569	CcSEcCtD
Lincomycin—Dermatitis—Gemcitabine—breast cancer	0.00056	0.000569	CcSEcCtD
Lincomycin—Tinnitus—Epirubicin—breast cancer	0.000558	0.000567	CcSEcCtD
Lincomycin—Vomiting—Fluorouracil—breast cancer	0.000556	0.000565	CcSEcCtD
Lincomycin—Rash—Fluorouracil—breast cancer	0.000551	0.00056	CcSEcCtD
Lincomycin—Dermatitis—Fluorouracil—breast cancer	0.00055	0.000559	CcSEcCtD
Lincomycin—Hypersensitivity—Paclitaxel—breast cancer	0.000548	0.000557	CcSEcCtD
Lincomycin—Nausea—Mitoxantrone—breast cancer	0.000542	0.000551	CcSEcCtD
Lincomycin—Nausea—Irinotecan—breast cancer	0.000542	0.000551	CcSEcCtD
Lincomycin—Pain—Docetaxel—breast cancer	0.000539	0.000548	CcSEcCtD
Lincomycin—Nausea—Gemcitabine—breast cancer	0.000528	0.000536	CcSEcCtD
Lincomycin—Pruritus—Paclitaxel—breast cancer	0.000526	0.000535	CcSEcCtD
Lincomycin—Erythema multiforme—Doxorubicin—breast cancer	0.000524	0.000532	CcSEcCtD
Lincomycin—Pain—Capecitabine—breast cancer	0.000522	0.000531	CcSEcCtD
Lincomycin—Nausea—Fluorouracil—breast cancer	0.000519	0.000527	CcSEcCtD
Lincomycin—Tinnitus—Doxorubicin—breast cancer	0.000517	0.000525	CcSEcCtD
Lincomycin—Diarrhoea—Paclitaxel—breast cancer	0.000509	0.000517	CcSEcCtD
Lincomycin—Vertigo—Methotrexate—breast cancer	0.0005	0.000509	CcSEcCtD
Lincomycin—Body temperature increased—Docetaxel—breast cancer	0.000499	0.000507	CcSEcCtD
Lincomycin—Abdominal pain—Docetaxel—breast cancer	0.000499	0.000507	CcSEcCtD
Lincomycin—Leukopenia—Methotrexate—breast cancer	0.000499	0.000507	CcSEcCtD
Lincomycin—Urticaria—Capecitabine—breast cancer	0.000485	0.000493	CcSEcCtD
Lincomycin—Body temperature increased—Capecitabine—breast cancer	0.000483	0.000491	CcSEcCtD
Lincomycin—Abdominal pain—Capecitabine—breast cancer	0.000483	0.000491	CcSEcCtD
Lincomycin—Vomiting—Paclitaxel—breast cancer	0.000473	0.000481	CcSEcCtD
Lincomycin—Rash—Paclitaxel—breast cancer	0.000469	0.000477	CcSEcCtD
Lincomycin—Dermatitis—Paclitaxel—breast cancer	0.000469	0.000476	CcSEcCtD
Lincomycin—Vertigo—Epirubicin—breast cancer	0.000468	0.000476	CcSEcCtD
Lincomycin—Leukopenia—Epirubicin—breast cancer	0.000467	0.000474	CcSEcCtD
Lincomycin—Hypersensitivity—Docetaxel—breast cancer	0.000465	0.000472	CcSEcCtD
Lincomycin—Anaphylactic shock—Methotrexate—breast cancer	0.000455	0.000462	CcSEcCtD
Lincomycin—Hypersensitivity—Capecitabine—breast cancer	0.00045	0.000457	CcSEcCtD
Lincomycin—Pruritus—Docetaxel—breast cancer	0.000446	0.000453	CcSEcCtD
Lincomycin—Nausea—Paclitaxel—breast cancer	0.000442	0.000449	CcSEcCtD
Lincomycin—Vertigo—Doxorubicin—breast cancer	0.000433	0.00044	CcSEcCtD
Lincomycin—Pruritus—Capecitabine—breast cancer	0.000432	0.000439	CcSEcCtD
Lincomycin—Leukopenia—Doxorubicin—breast cancer	0.000432	0.000439	CcSEcCtD
Lincomycin—Diarrhoea—Docetaxel—breast cancer	0.000432	0.000439	CcSEcCtD
Lincomycin—Anaphylactic shock—Epirubicin—breast cancer	0.000425	0.000432	CcSEcCtD
Lincomycin—Hypotension—Methotrexate—breast cancer	0.000425	0.000432	CcSEcCtD
Lincomycin—Shock—Epirubicin—breast cancer	0.000419	0.000425	CcSEcCtD
Lincomycin—Diarrhoea—Capecitabine—breast cancer	0.000418	0.000425	CcSEcCtD
Lincomycin—Vomiting—Docetaxel—breast cancer	0.000401	0.000407	CcSEcCtD
Lincomycin—Rash—Docetaxel—breast cancer	0.000398	0.000404	CcSEcCtD
Lincomycin—Hypotension—Epirubicin—breast cancer	0.000397	0.000404	CcSEcCtD
Lincomycin—Dermatitis—Docetaxel—breast cancer	0.000397	0.000404	CcSEcCtD
Lincomycin—Anaphylactic shock—Doxorubicin—breast cancer	0.000394	0.0004	CcSEcCtD
Lincomycin—Pain—Methotrexate—breast cancer	0.000389	0.000395	CcSEcCtD
Lincomycin—Vomiting—Capecitabine—breast cancer	0.000388	0.000395	CcSEcCtD
Lincomycin—Shock—Doxorubicin—breast cancer	0.000387	0.000394	CcSEcCtD
Lincomycin—Rash—Capecitabine—breast cancer	0.000385	0.000391	CcSEcCtD
Lincomycin—Dermatitis—Capecitabine—breast cancer	0.000385	0.000391	CcSEcCtD
Lincomycin—Nausea—Docetaxel—breast cancer	0.000375	0.000381	CcSEcCtD
Lincomycin—Hypotension—Doxorubicin—breast cancer	0.000368	0.000374	CcSEcCtD
Lincomycin—Pain—Epirubicin—breast cancer	0.000364	0.00037	CcSEcCtD
Lincomycin—Nausea—Capecitabine—breast cancer	0.000363	0.000369	CcSEcCtD
Lincomycin—Urticaria—Methotrexate—breast cancer	0.000361	0.000367	CcSEcCtD
Lincomycin—Abdominal pain—Methotrexate—breast cancer	0.000359	0.000365	CcSEcCtD
Lincomycin—Body temperature increased—Methotrexate—breast cancer	0.000359	0.000365	CcSEcCtD
Lincomycin—Urticaria—Epirubicin—breast cancer	0.000338	0.000343	CcSEcCtD
Lincomycin—Pain—Doxorubicin—breast cancer	0.000337	0.000342	CcSEcCtD
Lincomycin—Abdominal pain—Epirubicin—breast cancer	0.000336	0.000342	CcSEcCtD
Lincomycin—Body temperature increased—Epirubicin—breast cancer	0.000336	0.000342	CcSEcCtD
Lincomycin—Hypersensitivity—Methotrexate—breast cancer	0.000335	0.00034	CcSEcCtD
Lincomycin—Pruritus—Methotrexate—breast cancer	0.000322	0.000327	CcSEcCtD
Lincomycin—Hypersensitivity—Epirubicin—breast cancer	0.000313	0.000318	CcSEcCtD
Lincomycin—Urticaria—Doxorubicin—breast cancer	0.000313	0.000318	CcSEcCtD
Lincomycin—Abdominal pain—Doxorubicin—breast cancer	0.000311	0.000316	CcSEcCtD
Lincomycin—Body temperature increased—Doxorubicin—breast cancer	0.000311	0.000316	CcSEcCtD
Lincomycin—Diarrhoea—Methotrexate—breast cancer	0.000311	0.000316	CcSEcCtD
Lincomycin—Pruritus—Epirubicin—breast cancer	0.000301	0.000306	CcSEcCtD
Lincomycin—Diarrhoea—Epirubicin—breast cancer	0.000291	0.000296	CcSEcCtD
Lincomycin—Hypersensitivity—Doxorubicin—breast cancer	0.00029	0.000295	CcSEcCtD
Lincomycin—Vomiting—Methotrexate—breast cancer	0.000289	0.000294	CcSEcCtD
Lincomycin—Rash—Methotrexate—breast cancer	0.000287	0.000291	CcSEcCtD
Lincomycin—Dermatitis—Methotrexate—breast cancer	0.000286	0.000291	CcSEcCtD
Lincomycin—Pruritus—Doxorubicin—breast cancer	0.000278	0.000283	CcSEcCtD
Lincomycin—Vomiting—Epirubicin—breast cancer	0.00027	0.000275	CcSEcCtD
Lincomycin—Nausea—Methotrexate—breast cancer	0.00027	0.000274	CcSEcCtD
Lincomycin—Diarrhoea—Doxorubicin—breast cancer	0.000269	0.000274	CcSEcCtD
Lincomycin—Rash—Epirubicin—breast cancer	0.000268	0.000273	CcSEcCtD
Lincomycin—Dermatitis—Epirubicin—breast cancer	0.000268	0.000272	CcSEcCtD
Lincomycin—Nausea—Epirubicin—breast cancer	0.000253	0.000257	CcSEcCtD
Lincomycin—Vomiting—Doxorubicin—breast cancer	0.00025	0.000254	CcSEcCtD
Lincomycin—Rash—Doxorubicin—breast cancer	0.000248	0.000252	CcSEcCtD
Lincomycin—Dermatitis—Doxorubicin—breast cancer	0.000248	0.000252	CcSEcCtD
Lincomycin—Nausea—Doxorubicin—breast cancer	0.000234	0.000238	CcSEcCtD
